Theolytics Limited
Clinical trials sponsored by Theolytics Limited, explained in plain language.
-
New virus therapy tested for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis is an early safety study testing a new treatment called THEO-260 for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The main goal is to find a safe dose and see what side effects occur. Participants will receive six doses of…
Phase: PHASE1 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Virus therapy tested for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis early-stage trial is testing a new virus-based therapy called THEO-260 for women with advanced ovarian cancer that has stopped responding to standard platinum chemotherapy. The main goals are to find the safest and most effective dose and to see if the treatment shows signs …
Phase: PHASE1, PHASE2 • Sponsor: Theolytics Limited • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC